Protective effect of Nasturtium officinale R. Br and quercetin against cyclophosphamide-induced hepatotoxicity in rats.

Molecular Biology Reports
Amir Hossein DoustimotlaghArash Asfaram

Abstract

Cyclophosphamide (CPA) is used in the management of autoimmune conditions and malignant illnesses. However, its therapeutic use is limited because of its severe side effects, especially hepatotoxicity attributed to oxidative stress. Nasturtium officinale R. Br (watercress or WC) has pharmacological properties, such as anti-inflammation, and antioxidant activities. Therefore, the present study was design to assess effects of WC or its active ingredient, quercetin (QE), against CPA-induced hepatotoxicity. For this study, 49 male Wistar rats (200-250 g) were randomly selected and categorized into seven equal groups. The animals were pre- and post-treated with both hydroalcoholic extract of WC (500 mg/kg) and quercetin (75 mg/kg) for 10 consecutive days, and intraperitoneal administration of CPA (200 mg/kg) was performed on only day 10, one hour before the last dose of WC or quercetin. On day 11, all the animals were sacrificed, and their blood and liver were gathered for evaluation of the liver enzyme, hepatic oxidative stress markers, antioxidant enzymes activity, and hematoxylin and eosin staining. CPA significantly increased malondialdehyde (MDA), protein carbonyl (PCO) and nitric oxide (NO) levels and liver biomarkers. Otherwi...Continue Reading

References

Jun 1, 1979·Analytical Biochemistry·H OhkawaK Yagi
Jul 1, 1997·Cancer Treatment Reviews·N I WeijlS Osanto
Feb 8, 2007·The American Journal of Clinical Nutrition·Chris I R GillIan R Rowland
Nov 6, 2007·Journal of Ethnopharmacology·Seifollah Bahramikia, Razieh Yazdanparast
Mar 7, 2008·Journal of Agricultural and Food Chemistry·Ascensión Martínez-SánchezFederico Ferreres
Mar 8, 2008·Chemico-biological Interactions·Razieh YazdanparastAmin Ardestani
Dec 28, 2010·Journal of Acupuncture and Meridian Studies·Seifollah Bahramikia, Razieh Yazdanparast
Oct 29, 2013·Pharmaceutical Biology·Heibatollah SadeghiFouad Mehraban
Apr 20, 2014·Journal of Cancer Research and Clinical Oncology·Mousa O Germoush, Ayman M Mahmoud
Aug 12, 2014·The Journal of Nutritional Biochemistry·Shih-Yi LinChun-Jung Chen
Mar 21, 2017·Pharmaceutical Biology·Esmaeel Panahi KokhdanMahmoud Reza Aghamaali
Jul 12, 2017·Fundamental & Clinical Pharmacology·Mehdi GoudarziSaeed Mehrzadi
Mar 20, 2018·Current Atherosclerosis Reports·Nathan S Bryan
Jun 2, 2018·Research in Pharmaceutical Sciences·Amir Hossein DoustimotlaghAbolfazl Golestani
Oct 3, 2018·Research in Pharmaceutical Sciences·Esmaeel Panahi KokhdanMahmoud Reza Aghamaali
Oct 18, 2019·Research in Pharmaceutical Sciences·Heibatollah SadeghiAmir Hossein Doustimotlagh

❮ Previous
Next ❯

Citations

Jan 29, 2021·Evidence-based Complementary and Alternative Medicine : ECAM·Moslem SedaghattalabAminollah Pourshohod
May 27, 2021·Evidence-based Complementary and Alternative Medicine : ECAM·Izadpanah GheitasiAmir Hossein Doustimotlagh

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
MDA

Software Mentioned

SPSS

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.